BioPharma Credit (BPCP)

71.50p
   
  • Change Today:
    -0.100p
  • 52 Week High: 74.20
  • 52 Week Low: 66.20
  • Currency: UK Pounds
  • Shares Issued: 1,129.23m
  • Volume: 32,737
  • Market Cap: £807.40m

Dividend Data

  31-Dec-2531-Dec-2431-Dec-2331-Dec-2231-Dec-21
1st Interim1.75¢1.75¢1.75¢1.75¢n/a
2nd Interim1.75¢1.75¢1.75¢1.75¢n/a
3rd Interim1.75¢1.75¢1.75¢1.75¢n/a
4th Interim1.75¢1.75¢1.75¢1.75¢n/a
Total Dividend7.00¢7.00¢7.00¢7.00¢n/a
For more dividend details, click here

Fundamentals

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Turnover 139.75 148.63 155.36 212.22 127.63
Operating Profit/(Loss) 112.33 122.27 132.40 176.39 108.73
Net Interest n/a n/a n/a n/a n/a
Profit Before Tax 112.33 122.27 132.40 176.39 108.73
Profit After Tax 112.33 122.27 132.40 176.39 108.73
Total Dividend Paid n/a n/a n/a n/a n/a
Retained Profit/(Loss) for the Financial Year 112.33 122.27 132.40 176.39 108.73
Earnings per Share - Basic 9.86¢ 10.00¢ 10.11¢ 12.93¢ 7.91¢
Earnings per Share - Diluted 9.86¢ 10.00¢ 10.11¢ 12.93¢ 7.91¢
Earnings per Share - Adjusted 9.86¢ 10.00¢ 10.11¢ 12.93¢ 7.91¢
Dividend per Share 7.00¢ 7.00¢ 7.00¢ 7.00¢ 7.00¢
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Fixed Assets          
Intangible Assets n/a n/a n/a n/a n/a
Tangible Assets n/a n/a n/a n/a n/a
Fixed Investments 1,102.23 1,162.20 1,201.36 1,223.65 1.27
  1,102.23 1,162.20 1,201.36 1,223.65 1.27
Current Assets          
Stocks n/a n/a n/a n/a n/a
Debtors 53.60 31.80 20.32 19.84 0.01
Cash at Bank & in Hand 12.59 5.62 135.05 120.53 0.09
Other Current Assets n/a n/a n/a n/a n/a
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 1,168.42 1,199.62 1,356.73 1,364.02 1.37
           
Liabilities          
Creditors: Amount Due Within 1 Year 17.56 17.88 15.87 26.30 0.01
Net Current Assets n/a n/a 139.50 1,337.71 0.09
           
Creditors: Amount Due Over 1 Year n/a n/a n/a n/a n/a
Provisions for Liabilities & Charges n/a n/a n/a n/a n/a
Other Liabilities n/a 0.06 n/a 0.26 n/a
Total Liabilities 17.56 17.94 15.87 26.56 0.01
           
Net Assets 1,150.86 1,181.68 1,340.86 1,337.45 1.36
           
Capital & Reserves          
Called Up Share Capital 13.74 13.74 13.74 13.74 0.01
Share Premium Account 607.12 607.12 607.12 607.12 0.61
Other Reserves 493.91 526.68 633.47 672.69 0.72
Profit & Loss Account 36.09 34.14 86.53 43.90 0.02
Shareholders Funds 1,150.86 1,181.68 1,340.86 1,337.45 1.36
           
Minority Interests n/a n/a n/a n/a n/a
Capital Employed 1,150.86 1,181.68 1,340.86 1,337.45 1.36
Cash Flow 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Net Cash Flow From Operating Activities 91.10 111.91 123.18 184.28 0.10
Returns On Investment & Servicing of Finance n/a n/a n/a n/a n/a
Taxation Paid n/a n/a n/a n/a n/a
Capital Expenditure 77.48 39.07 (1.66) 48.19 (0.09)
Acquisitions & Disposals n/a n/a n/a n/a n/a
Equity Dividends Paid (110.38) (174.66) n/a (156.54) (0.10)
Management of Liquid Resources n/a n/a n/a n/a n/a
Financing (51.27) (105.75) (106.99) (50.09) n/a
Net Increase/Decrease In Cash 6.93 (129.43) 14.53 25.85 (0.10)
Ratios 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
PE Ratio 9.4 9.5 8.9 8.2 12.6
PEG n/a n/a n/a 0.1 0.3
EPS Growth -1% -1% -22% 64% 36%
Dividend Yield 7.5% 7.4% 7.7% 6.6% 7.0%
Dividend Cover 1.41 1.43 1.44 1.85 1.13
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cashflow Per Share 8.07¢ 9.91¢ 10.91¢ 16.32¢ 0.009¢
Pre-tax Profit per Share 9.95¢ 10.83¢ 11.72¢ 15.62¢ 9.63¢
Cash Increase / Decrease per Share 0.61¢ (11.46¢) 1.29¢ 2.29¢ 0.009¢
Turnover per Share 12.38¢ 13.16¢ 13.76¢ 18.79¢ 11.30¢
Net Asset Value per Share 101.92¢ 104.64¢ 118.74¢ 118.44¢ 0.12¢
Operating Margin 80.38% 82.26% 85.22% 83.12% 85.19%
ROCE 9.76% 10.35% 9.87% 13.19% 7,973.06%
Net Gearing 0.43% 1.04% n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.

 

Top of Page